2022

1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

   Clinical cancer research : an official journal of the American Association for Cancer Research

2. Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group

   Blood cancer journal, Vol. 12, Núm. 4, pp. 76